A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:1
|
作者
Fukushima, Daizo [1 ]
Imai, Shigeki [2 ]
Nishino, Noriyuki [1 ]
Hamada, Kohichi [3 ]
Horikawa, Yoshinori [1 ]
Shiwa, Yoshiki [1 ]
Nishida, Shinya [1 ]
Koyanagi, Ryota [3 ]
Wada, Hitoshi [4 ]
Sakuma, Hideo [5 ]
机构
[1] Southern Tohoku Gen Hosp, Dept Gastroenterol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[2] Southern Tohoku Res Inst Neurosci, Dept Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[3] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima 9601295, Japan
[4] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan
[5] Southern Tohoku Res Inst Neurosci, Dept Pathol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy; DRUG-ELUTING BEADS; ARTERIOPORTAL SHUNT; EFFICACY; SAFETY;
D O I
10.1007/s12328-020-01124-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:8
相关论文
共 50 条
  • [41] Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
    Liu, Po-Hong
    Lee, Yun-Hsuan
    Hsia, Cheng-Yuan
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Chiou, Yi-You
    Lin, Han-Chieh
    Huo, Teh-Ia
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) : 1825 - 1833
  • [42] Pathological Complete Remission of Advanced Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis by Hepatic Arterial Infusion Chemotherapy
    Kim, Yong Gil
    Eun, Jong Ryul
    Kim, Tae Nyeun
    Lee, Heon Ju
    Kim, Jae Woon
    Chang, Jay Chun
    Yun, Sung Su
    Choi, Joon Hyuk
    GUT AND LIVER, 2010, 4 (02) : 266 - 269
  • [44] Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy
    Lei Zhang
    BinYan Zhong
    Bo Hu
    Wei Li
    Peng Huang
    Shen Zhang
    JinJin Song
    JianSong Ji
    CaiFang Ni
    Journal of Interventional Medicine, 2020, 3 (04) : 201 - 207
  • [45] The efficacy of surgery and transarterial chemoembolization for hepatocellular carcinoma patients with portal vein tumor thrombus
    Yang, Hong-Zhi
    Nong, Wen-Wei
    Zhang, Yong-Quan
    Hou, Hai-Ling
    Huang, Wen-Wen
    Li, Gang
    Cong, Feng-Yun
    Ye, Hai-Hong
    Xu, Jing-Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 5969 - 5977
  • [46] Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
    Tong-Chun Xue
    Xiao-Ying Xie
    Lan Zhang
    Xin Yin
    Bo-Heng Zhang
    Zheng-Gang Ren
    BMC Gastroenterology, 13
  • [47] Efficacy of Transarterial Chemoembolization Targeting Portal Vein Tumor Thrombus in Patients with Hepatocellular Carcinoma
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Saito, Tomoko
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Maruyama, Hitoshi
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    ANTICANCER RESEARCH, 2014, 34 (08) : 4231 - 4237
  • [48] Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
    Xue, Tong-Chun
    Xie, Xiao-Ying
    Zhang, Lan
    Yin, Xin
    Zhang, Bo-Heng
    Ren, Zheng-Gang
    BMC GASTROENTEROLOGY, 2013, 13
  • [49] Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization
    Liang, Hongyuan
    Cui, Peng
    Guo, Qiyong
    Mao, Xiaonan
    Wen, Feng
    Sun, Wei
    Shan, Ming
    Lu, Zaiming
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E331 - E341
  • [50] Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients
    Liu, Lei
    Zhang, Cheng
    Zhao, Yan
    Qi, Xingshun
    Chen, Hui
    Bai, Wei
    He, Chuangye
    Guo, Wengang
    Yin, Zhanxin
    Fan, Daiming
    Han, Guohong
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014